2 completed. 2 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 2 | Completed 2 |
Follow L 749345: new trials by email Literature Review of L 749345 trials Research Report on L 749345
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Ertapenem Sodium (MK-0826) Versus Piperacillin/Tazobactam Sodium for the Treatment of Diabetic Foot Infections in Chinese Adults (MK-0826-061) Ertapenem sodium, Piperacillin/tazobactam sodium, Piperacillin/tazobactam-matching placebo - Infection; Diabetic Foot | Phase 3 | Completed | Merck Sharp & Dohme LLC | 565 | 2011-09-02 | 2018-08-27 |
| Efficacy and Safety of Ertapenem Sodium (MK-0826) Following Colorectal Surgery in Chinese Adults (MK-0826-056) ertapenem sodium, ceftriaxone sodium, placebo to metronidazole - Infection, Surgical Site Infection | Phase 3 | Completed | Merck Sharp & Dohme LLC | 599 | 2010-12-01 | 2017-03-22 |
Infections (2) · Diabetes Complications (1) · Diabetes Mellitus (1) · Diabetic Foot (1) · Osteomyelitis (1) · Soft Tissue Infections (1) · Surgical Wound Infection (1)